Lipsovir: Completed Phase III enrollment

MVIR B completed enrollment of 2,400 patients with recurrent cold sores in a placebo-controlled, U.S. and Canadian Phase III trial evaluating Lipsovir vs. acyclovir and placebo. GlaxoSmithKline plc (...